Resveratrol downregulates TNF-α-induced monocyte chemoattractant protein-1 in primary rat pulmonary artery endothelial cells by P38 mitogen-activated protein kinase signaling

References

• Smulders YM. Pathophysiology and treatment of haemodynamic instability in acute pulmonary embolism: the pivotal role of pulmonary vasoconstriction. Cardiovasc Res. 2000;48:23–33.11033105
   PubMed Web of Science ®Google Scholar
• Kimura H, Okada O, Tanabe N, et al. Plasma monocyte chemoattractant protein-1 and pulmonary vascular resistance in chronic thromboembolic pulmonary artery hypertension. Am J Respir Crit Care Med. 2001;164:319–324. doi:10.1164/ajrccm.164.2.200615411463608
   PubMed Web of Science ®Google Scholar
• Langer F, Schramm R, Bauer M, Tscholl D, Kunihara T, Schäfers HJ. Cytokine response to pulmonary thromboendarterectomy. Chest. 2004;126:135–141. doi:10.1378/chest.126.1.13515249454
   PubMed Web of Science ®Google Scholar
• Eagleton MJ, Henke PK, Luke CE, et al. Inflammation and intimal hyperplasia associated with experimental pulmonary embolism. J Vasc Surg. 2002;36:581–588.12218985
   PubMed Web of Science ®Google Scholar
• Rectenwald JE, Deatrick KB, Sukheepod P, et al. Experimental pulmonary embolism: effects of the thrombus and attenuation of pulmonary artery injury by low-molecular-weight heparin. J Vasc Surg. 2006;43:800–808. doi:10.1016/j.jvs.2005.12.01016616240
   PubMed Web of Science ®Google Scholar
• Jang M, Cai L, Udeani GO, et al. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science. 2007;275:218–220. doi:10.1126/science.275.5297.218
   Web of Science ®Google Scholar
• Cullen JP, Morrow D, Jin Y, et al. Resveratrol, apolyphenolic phytostilbene, inhibits endothelial monocyte chemotacticprotein-1 synthesis and secretion. J Vasc Res. 2007;44:75–84. doi:10.1159/00009815517191021
   PubMed Web of Science ®Google Scholar
• Rius C, Abu-Taha M, Hermenegildo C, et al. Trans- but not cis-resveratrol impairs angiotensin-ii-mediated vascular inflammation through inhibition of nf-kappa b activation and peroxisome proliferator activated receptor-gamma upregulation. J Immunol. 2010;185:3718–3727. doi:10.4049/jimmunol.100104320709957
   PubMed Web of Science ®Google Scholar
• Ulrich S, Loitsch SM, Rau O, et al. Peroxisome proliferator-activated receptor gamma as a molecular target of resveratrol-induced modulation of polyamine metabolism. Cancer Res. 2006;66:7348–7354. doi:10.1158/0008-5472.CAN-05-277716849586
   PubMed Web of Science ®Google Scholar
• Green SR, Han KH, Chen Y, et al. The cc chemokine mcp-1 stimulates surface expression of cx3cr1 and enhances the adhesion of monocytes to fractalkine/cx3cl1 via p38 mapk. J Immunol. 2006;176:7412–7420.16751386
   PubMed Web of Science ®Google Scholar
• Shimada H, Rajagopalan LE. Rho-kinase mediates lysophosphatidic acid-induced il-8 and mcp-1 production via p38 and jnk pathways in human endothelial cells. FEBS Lett. 2010;584:2827–2832. doi:10.1016/j.febslet.2010.04.06420434448
   PubMed Web of Science ®Google Scholar
• Shui H, Gao P, Si XY, Ding GH. Mycophenolic acid inhibits albumin-induced mcp-1 expression in renal tubular epithelial cells through the p38 mapk pathway. Mol Biol Rep. 2010;37:1749–1754. doi:10.1007/s11033-009-9599-y19578979
   PubMed Web of Science ®Google Scholar
• Runyon MS, Gellar MA, Sanapareddy N, Kline JA, Watts JA. Development and comparison of a minimally-invasive model of autologous clot pulmonary embolism in Sprague–dawley and Copenhagen rats. Thromb J. 2010;8:3. doi:10.1186/1477-9560-8-320181228
   PubMedGoogle Scholar
• Sener G, Topaloglu N, Sehirli AO, Ercan F, Gedik N. Resveratrol alleviates bleomycininduced lung injury in rats. Pulm Pharmacol Ther. 2007;20:642–649. doi:10.1016/j.pupt.2006.07.00317035056
   PubMed Web of Science ®Google Scholar
• Loberg RD, Ying C, Craig M, Yan L, Snyder LA, Pienta KJ. Ccl2 as an important mediator of prostate cancer growth in vivo through the regulation of macrophage infiltration. Neoplasia. 2007;9:556–562.17710158
   PubMed Web of Science ®Google Scholar
• Grumbles RM, Casella GTB, Rudinsky MJ, Godfrey S, Wood PM, Thomas CK. The immunophilin ligand fk506, but not the p38 kinase inhibitor sb203580, improvesfunction of adult rat muscle reinnervated from transplants of embryonic neurons. Neuroscience. 2005;130:619–630. doi:10.1016/j.neuroscience.2004.09.02415590146
   PubMed Web of Science ®Google Scholar
• Chun C, Yang W, Xueding C, et al. Resveratrol downregulates acute pulmonary thromboembolism-induced pulmonary artery hypertension via p38 mitogen-activated protein kinase and monocyte chemoattractant protein-1 signaling in rats. Life Sciences. 2012;90:721–727. doi:10.1016/j.lfs.2012.03.00822507635
   PubMed Web of Science ®Google Scholar
• Lee JC, Kumar S, Griswold DE, et al. Inhibition of p38 map kinase as a therapeutic strategy. Immunopharmacology. 2000;47:185–201.10878289
   PubMed Web of Science ®Google Scholar
• Watts JA, Zagorski J, Gellar MA, Stevinson BG, Kline JA. Cardiac inflammation contributes to right ventricular dysfunction following experimental pulmonary embolism in rats. J Mol Cell Cardiol. 2006;41:296–307. doi:10.1016/j.yjmcc.2006.05.01116814320
   PubMed Web of Science ®Google Scholar
• Battistini B. Modulation and roles of the endothelins in the pathophysiology of pulmonary embolism. Can J Physiol Pharmacol. 2003;81:555–569. doi:10.1139/y03-01712839267
   PubMed Web of Science ®Google Scholar
• Halici B, Sarinc US, Gunay E, et al. Assessment of inflammatory biomarkers and oxidative stress in pulmonary thromboembolism: follow-up results. Inflammation. 2014;37:1186–1190. doi:10.1007/s10753-014-9871-824531854
   PubMed Web of Science ®Google Scholar
• Strieter RM, Kunkel SL, Keane MP, Standiford TJ. Chemokines in lung injury Thomas A. Neff lecture. Chest. 1999;116:103–110. doi:10.1378/chest.116.suppl_1.103S
   PubMed Web of Science ®Google Scholar
• Wagenvoort CA. Pathology of pulmonary thromboembolism. Chest. 2005;107:10–17. doi:10.1378/chest.107.1_Supplement.10S
   Web of Science ®Google Scholar
• Wakabayashi I, Takeda Y. Inhibitory effects of resveratrol on MCP-1, IL-6, and IL-8 production in human coronary artery smooth muscle cells. Naunyn Schmiedebergs Arch Pharmacol. 2013;386(9):835–839. doi:10.1007/s00210-013-0877-923661232
   PubMed Web of Science ®Google Scholar
• Zhu X, Liu Q, Wang M, et al. Activation of Sirt1 by resveratrol inhibits TNF-α induced inflammation in fibroblasts. PLoS One. 2011;6(11):e27081. doi:10.1371/journal.pone.002708122069489
   PubMed Web of Science ®Google Scholar
• Park DW, Baek K, Kim JR, et al. Resveratrol inhibits foam cell formation via nadph oxidase 1-mediated reactive oxygen species and monocyte chemotactic protein-1. Exp Mol Med. 2009;41:171–179. doi:10.3858/emm.2009.41.3.02019293636
   PubMed Web of Science ®Google Scholar
• Zhu J, Yong W, Wu XH, et al. Anti-inflammatory effect of resveratrol on tnf-alpha-induced mcp-1 expression in adipocytes. Biochem Biophys Res Commun. 2008;369:471–477. doi:10.1016/j.bbrc.2008.02.03418291098
   PubMed Web of Science ®Google Scholar
• Gresele P, Pignatelli P, Guglielmini G, et al. Resveratrol, at concentrations attainable with moderate wine consumption, stimulates human platelet nitric oxide production. J Nutr. 2008;138:1602–1608. doi:10.1093/jn/138.9.160218716157
   PubMed Web of Science ®Google Scholar
• Chakraborty PK, Mustafi SB, Raha S. Pro-survival effects of repetitive low-grade oxidative stress are inhibited by simultaneous exposure to resveratrol. Pharmacol Res. 2008;58:281–289. doi:10.1016/j.phrs.2008.08.00718812223
   PubMed Web of Science ®Google Scholar